References

  1. WHO. Department of Communicable Disease SaR. 2002. http/www/WHO/hepatitis/200.htm. Accessed on 14 January 2013.

  2. Dongdem J T, Kampo S, Soyiri I N, Asebga P N, Ziem J B, & Sagoe K. Prevalence of hepatitis B virus infection among blood donors at the Tamale Teaching Hospital, Ghana. BMC Res Notes. 2012; 5: 115. PubMed | Google Scholar

  3. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22 707 men in Taiwan. Lancet. 1981; 2(8256):1129-1133. PubMed | Google Scholar

  4. Magnius LO, Espmark JA. New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol. 1972; 109(5):1017-1021. PubMed | Google Scholar

  5. Akinbami AA, Oshinaike OO, Dosunmu OA, Adeyemo TA, Adediran A, Akanmu S, Wright KO, llori S and Aile K. Seroprevalence of hepatitis B e antigen (HBe antigen) and B core antibodies (IgG anti-HBcore and IgM anti-HBcore) among hepatitis B surface antigen positive blood donors at a Tertiary Centre in Nigeria. BMC Research Notes. 2012; 5:167. PubMed | Google Scholar

  6. Otegbayo JA, Fasola FA, Abia A. Prevalence of hepatitis B surface and e- antigens, risk factors for virus acquisition and serum transaminase among blood donors. Nigeria Trop Gastroenterol. 2003; 24(4):196-197. PubMed | Google Scholar

  7. Sagnelli E, Stroffolini T, Mele A, Imparato M, Almasio P. Chronic Hepatitis B in Italy: new features of an old disease. Approaching the universal prevalence of Hepatitis Be Antigen negative cases and the eradication of Hepatitis D infection. Clin Infec Dis 2008; 46 (1): 110-113. PubMed | Google Scholar

  8. Tsukuma H, Oshima A, Hiyama T, Fujimoto I, Yamano H, Tanaka M. Time trends of the prevalences of hepatitis B e antigen positives among hepatitis B virus carriers in Japan. Int J Epidemiol. 1987;16(4):579-583. PubMed | Google Scholar

  9. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury: Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem. 2000; 46(12):2050-2068. PubMed | Google Scholar

  10. Seto WK, Lai CL, Ip PP, Fung J, Wong DK, Yuen JC, Hung IF, Yuen MF. A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B. PLoS One. 2012; 7(2):e32622. PubMed | Google Scholar